Skip to content

Optimal Timing of Coronary Artery Bypass Grafting in Hemodynamically Stable Patient After Myocardial Infarction and Definition of Poor Prognostic Factors. Pilot Study

Optimal Timing of Coronary Artery Bypass Grafting in Hemodynamically Stable Patient After Myocardial Infarction and Definition of Poor Prognostic Factors. Pilot Study

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03863158
Enrollment
476
Registered
2019-03-05
Start date
2007-01-01
Completion date
2019-02-28
Last updated
2019-03-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cardiac Surgery

Brief summary

Acute coronary syndromes (ACS) represent the leading cause of death in France. Their incidence is increasing due to population aging and to the persistence of cardiovascular risk factors. Currently, revascularization surgery remains outside the emergency treatment, because early performed, it tends to lead to extension and hemorrhage of the infarcted area, because of the CPB, aortic clamping, cardioplegia, and other heart manipulation. However, CABG are indicated as an emergency in some situations of STEMI: Threat of infarction of an extended territory without favorable anatomy to angioplasty, anatomy not favorable to angioplasty associated with cardiogenic shock or persistent ischemia, acute complications of myocardial infarction (massive mitral insufficiency, interventricular communication, parietal rupture) requiring surgery under CPB with concomitant bypass surgery or failure of angioplasty (proximal coronary dissection). Operative mortality is high; 15 to 20% for patients operated 12 to 48 hours after AMI and 4-5% for those operated after 48 hours. Nevertheless, it seems legitimate to study if there would be a place for primary surgical revascularization in case of patient with hemodynamically stable ACS, in order to limit myocardial ischemia, spread of necrosis, to limit the risk of recurrence, and the consequences of low cardiac output. Performing a complete early surgical revascularization could limit the ischemia-reperfusion syndrome and anticipate the occurrence of cardiogenic shock.

Detailed description

Trial on medical records only

Interventions

OTHERNo intervention

No intervention / medical records only

Sponsors

BOUCHOT Olivier
CollaboratorUNKNOWN
LAUBRIET-JAZAYERI Aline
CollaboratorUNKNOWN
Centre Hospitalier La Chartreuse
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 99 Years
Healthy volunteers
No

Inclusion criteria

* Patients presenting acute myocardial infarction with hemodynamic stability at the diagnosis * Patients undergoing coronary artery bypass in Dijon University hospital

Exclusion criteria

* Patients with Acute pulmonary oedema * Patients with cardiorespiratory arrest before coronary angiography * hemodynamically unstable patient at diagnosis * patients requiring combined surgery * patients with unstable angina

Design outcomes

Primary

MeasureTime frameDescription
Correlation between the mortality rate and the delay between the surgical revascularization and the date of diagnosis of mycardial infaction in hemodynamically stable patients30 daysDelay in days between diagnosis and surgery

Secondary

MeasureTime frameDescription
Determine the predictors of intra-hospital mortality rate in hemodynamically stable patients operated of coronary bypass30 daysEvaluate the results of evaluations carried out in patients who died compared to patients who did not die and the normal population

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026